DBV Technologies (DBVT) Long-Term Investments (2015 - 2019)

DBV Technologies (DBVT) reported Long-Term Investments of $18.3 million for Q4 2019, up 165.03% year-over-year from $6.9 million in Q4 2018, and up 165.03% quarter-over-quarter from $6.9 million in Q4 2018.

DBV Technologies (DBVT) Long-Term Investments (2015 - 2019) Analysis & Trends

DBV Technologies (DBVT) has 5 years of Long-Term Investments data on file, last reported at $18.3 million in Q4 2019.

  • Long-Term Investments for Q4 2019 came in at $18.3 million, up 165.03% year-over-year; the trailing twelve-month figure through Dec 2019 was $18.3 million (up 165.03% YoY), and the FY2019 annual result was $18.3 million, up 165.03% from the prior year.
  • Long-Term Investments climbed to $18.3 million in Q4 2019 per DBVT's latest filing, from $6.9 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $18.3 million in Q4 2019 and troughed at $3.0 million in Q4 2016.
  • A 5-year average of $6.9 million and a median of $3.5 million in 2017 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2016 and 2019: Long-Term Investments dropped 0.26% in 2016, then surged 165.03% in 2019.
  • A 5-year view of Long-Term Investments shows it stood at $3.0 million in 2015, then declined by 0.26% to $3.0 million in 2016, then grew by 19.66% to $3.5 million in 2017, then surged by 94.17% to $6.9 million in 2018, then surged by 165.03% to $18.3 million in 2019.
  • Business Quant data shows DBVT's Long-Term Investments at $18.3 million in Q4 2019, $6.9 million in Q4 2018, and $3.5 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 18.25 Mn
Dec 31, 2018 6.89 Mn
Dec 31, 2017 3.55 Mn
Dec 31, 2016 2.96 Mn
Dec 31, 2015 2.97 Mn